It’s coming home.
Our BSR Best Practice Award is coming home.
Thank you to the BSR @RheumatologyUK for the award and to all members of our Rheumatology team at Royal Berkshire Hospital @RBNHSFT it’s special as our AHPs and trainees are also here with us at #BSR24
‘Laura Coates has been an inspiring researcher. She has developed many pragmatic patient focused trials. Her work in PPI (OPEN ARMS) is truly remarkable.’ @DrLauraCoates@BotnarOxford
Are you living with #psoriasis? Then we need you!
@UniofOxford researchers are trying to understand who is more likely to develop psoriatic arthritis in a new study.
If you suffer from psoriasis and would like to help with our research, find out more! https://t.co/9Dfe6lMYbu
After careful co-design with some amazing patients, we are launching the @Hippocrates_IMI funded HPOS study. Please join if you have psoriasis so we can work towards predicting and preventing psoriatic arthritis
We didn't have parties to "boost morale"
We didn't have quiz nights
We didn't have champagne
We watched our colleagues die though
We were STEEPED in death
We kept going
We had to
We kept on
So don't you DARE say your parties were "necessary" @borisjohnson
You make me sick.
ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance https://t.co/r6VxSAFCBQ
NEW RESEARCH—What is the optimal dose of #methotrexate to administer with a TNF inhibitor? The MIRACLE trial shows that adalimumab + reduced-dose methotrexate is non-inferior to adalimumab + maximal-dose methotrexate in patients with #rheumatoidarthritis https://t.co/RofdRqNbvG
Excellent talk by Dr. Jeff Curtis on vaccinations in patients with rheumatic disease:
💉high dose flu conditionally recommended for all adult patients on immunosuppression
💉hold MTX 2 weeks after flu vaccination if disease allows (flare rate 10.6% vs. 5.1% if MTX cont.)